These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7777107)

  • 21. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
    McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
    Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of uric acid, xanthine and hypoxanthine by brush-border membrane vesicles from mouse small intestine.
    Shaw MI; Parsons DS
    Biochim Biophys Acta; 1984 Dec; 778(3):530-8. PubMed ID: 6509051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma oxipurinol concentrations during allopurinol therapy.
    Emmerson BT; Gordon RB; Cross M; Thomson DB
    Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal hypouricemia associated with hyperoxypurinemia due to decreased renal excretion of oxypurines: a new defect in renal purine transport.
    Kawachi M; Kono N; Mineo I; Kiyokawa H; Nakajima H; Shimizu T; Ono A; Nishimura T; Yorifuji S; Kuwajima M
    Adv Exp Med Biol; 1991; 309A():239-42. PubMed ID: 1789216
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of disorders of purine metabolism for the kidney and the urinary tract.
    de Vries A; Sperling O
    Ciba Found Symp; 1977; (48):179-206. PubMed ID: 24529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
    Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
    Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
    Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
    J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased renal clearance of xanthine and hypoxanthine in a patient with renal hypouricemia: a new defect in renal handling of purines.
    Kawachi M; Kono N; Kiyokawa H; Mineo I; Nakajima H; Shimizu T; Yorifuji S; Kuwajima M; Tarui S
    Nephron; 1992; 61(4):428-31. PubMed ID: 1501740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of purines to xanthine by Methanococcus vannielii.
    DeMoll E; Tsai L
    Arch Biochem Biophys; 1986 Nov; 250(2):440-5. PubMed ID: 3777942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.
    Chu WY; Annink KV; Nijstad AL; Maiwald CA; Schroth M; Bakkali LE; van Bel F; Benders MJNL; van Weissenbruch MM; Hagen A; Franz AR; Dorlo TPC; Allegaert K; Huitema ADR;
    Clin Pharmacokinet; 2022 Feb; 61(2):321-333. PubMed ID: 34617261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
    Watts RW; Snedden W; Parker RA
    Clin Sci; 1971 Aug; 41(2):153-8. PubMed ID: 5564305
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic and metabolic regulation of purine base transport in Neurospora crassa.
    Tsao TF; Marzluf GA
    Mol Gen Genet; 1976 Dec; 149(3):347-55. PubMed ID: 139563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual hypoxanthine hydroxylation system in hepatopancreas of Helix pomatia (Gastropoda).
    Jezewska MM; Kamiński ZW
    Acta Biochim Pol; 1984; 31(1):161-72. PubMed ID: 6547015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic disorder of purine nucleotide in patients with chronic renal failure].
    Hosoya T; Tabe A; Hayashi T; Sakai O
    Nihon Rinsho; 1992 Jan; 50 Suppl():544-8. PubMed ID: 1578736
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol.
    Nihei H; Kanemitsu H; Tamura A; Oka H; Sano K
    Neurosurgery; 1989 Oct; 25(4):613-7. PubMed ID: 2797398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of uric acid formation.
    N Engl J Med; 1968 Feb; 278(6):331-2. PubMed ID: 5638350
    [No Abstract]   [Full Text] [Related]  

  • 40. Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.
    Shaw MI; Parsons DS
    Clin Sci (Lond); 1984 Mar; 66(3):257-67. PubMed ID: 6692658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.